Sentiss Pharma is a finished-dose manufacturer based in India. It appears in 14 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with UZPHARM (UZ) and US FDA. Its GMP standing is certified by EMA and UZPHARM (UZ). Its most recent recorded inspection, by US FDA, closed on 14 May 2019 as OAI. Customs aggregates show $58.8M of exports covering 1,294 molecules to 12 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Solan, India | 3008250236 |
| Nalagarh, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| UZPHARM (UZ) | 12 | 1 |
| US FDA | 2 | None |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $49K | 2 |
| 2025 | Not reported | $58.8M | 12 |
| 2024 | Not reported | $63.4M | 11 |
| 2023 | Not reported | $58.2M | 9 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Sentiss Pharma comes back tiered against every other supplier able to file there.
Start for free